TP53 and small cell lung carcinoma: This suggested that the pathogenesis of SCLC with intact RB1 and TP53 may be mediated by an entirely distinct mechanism; however, further details on clinicopathologic characteristics of such tumors and analysis of this phenomenon at scale have been lacking.